Novartis Investigative Site

Williamsburg, Michigan 49690

0 studies enrolling now · 2 studies all time

What they study most

Age Related Macular Degeneration (AMD), Choroidal Neovascularization, Macular Degeneration

Studies at this site

• A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD) — Completed
• Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization — Completed